@article{article, title  = {{An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International}},

 publisher = {{Publishing House Zaslavsky}},

 url = {{https://eprints.whiterose.ac.uk/190730/ }},

 year = {{2022}},

 month = {{5}},

 author = {{Müller R-U and Lianne Messchendorp A and Birn H and Capasso G and Cornec-Le Gall E and Devuyst O and Eerde AV and Guirchoun P and Harris T and Hoorn EJ and Knoers NVAM et al}},

 doi = {{10.22141/2307-1257.11.1.2022.357}},

 volume = {{11}},

 journal = {{Kidneys}},

 issue = {{1}},

 pages = {{37-39}},

 note = {{Accessed on 2024/12/22}}}